Dietary supplementation with the oral probiotic BLIS K12 may improve immune parameters in healthy people performing a high-intensity training (HIT) program, says a new RCT.
Probiotic player Probi has completed the first commercial production batches of a dairy-free BLIS K12 at its US manufacturing site, with the new BLIS strains available shortly to customers around the world.
Probiotic specialists Probi has taken a stake in Blis Technologies and formed a partnership with the New Zealand-based oral probiotics firm that sees Probi manufacture select bacterial strains from Blis’ collection.
